Histotripsy: Recent Advances, Clinical Applications, and Future Prospects
Cancers · 19.09.2025 · 17 (18) · 3072
DOI: 10.3390/cancers17183072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 19.09.2025. Verfasst von Mustaqueem Pallumeera und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University College of Medicine, Columbus, OH 43210, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Histotripsy is a novel, non-invasive ultrasound-based ablative therapy that destroys tissue through focused cavitation. As solid tumors continue to be a major global health burden, there is interest in image-guided ablation techniques that reduce collateral damage and promote immune activation. This narrative review aims to synthesize current advancements, clinical applications, limitations, and future directions of histotripsy in both oncologic and non-oncologic contexts. A comprehensive literature search was conducted from database inception to July 2025. Search terms included combinations of subject headings and keywords such as “histotripsy,” “mechanical ablation,” “ultrasound,” and “solid tumors.” Boolean operators and truncation were used to increase sensitivity. Peer-reviewed studies were included, encompassing preclinical, clinical, and review articles. Reference lists of relevant articles were examined to identify additional sources. Histotripsy has shown strong potential in the treatment of tumors involving the liver, pancreas, kidney, brain, and cardiovascular system. It offers real-time imaging guidance, sharp lesion boundaries, and minimal damage to surrounding structures. Early clinical trials have demonstrated encouraging safety and efficacy, particularly in liver and kidney tumors. Its ability to preserve critical anatomy and stimulate innate and adaptive immune responses through the release of cellular debris and cytokines offers advantages over thermal ablation. Limitations include acoustic aberration, motion-related targeting challenges, and the need for further long-term clinical data. Histotripsy represents a promising advancement in noninvasive tumor ablation. Continued clinical investigation and technological refinement are necessary to validate its therapeutic value and define its role within comprehensive cancer care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Ohio State University College of Medicine, Columbus, OH 43210, USA.
- Northeast Ohio Medical University, Rootstown, OH 44272, USA.
- Division of Vascular and Interventional Radiology, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
ORCID-Profile: Mustaqueem Pallumeera, Jonathan C Giang, Mina S Makary
Zitieren
APA
Pallumeera, M., Hong, M., Giang, J. C., & Makary, M. S. (2025). Histotripsy: Recent Advances, Clinical Applications, and Future Prospects. Cancers, 17(18), 3072. https://doi.org/10.3390/cancers17183072
Vancouver
Pallumeera M, Hong M, Giang JC, Makary MS. Histotripsy: Recent Advances, Clinical Applications, and Future Prospects. Cancers. 2025;17(18):3072. doi:10.3390/cancers17183072
BibTeX
@article{Pallumeera2025,
author = {Pallumeera, Mustaqueem and Hong, Marcus and Giang, Jonathan C and Makary, Mina S},
title = {Histotripsy: Recent Advances, Clinical Applications, and Future Prospects},
journal = {Cancers},
year = {2025},
volume = {17},
number = {18},
pages = {3072},
doi = {10.3390/cancers17183072}
}
EUVIMED